Advising patients on decision making with input based on evidence should be the minimum for primary care physicians. But according to a new BMJ study, only 18 percent of clinical recommendations are based on high-quality evidence.

Advanced Sterilization Products (ASP) have received clearance from the U.S. Food and Drug Administration for the STERRAD VELOCITY Biological Indicator (BI) System. This system, which tests tools for proper sterilization, is able to cut time when receiving test results from hours to 30 minutes.

The “internet of things” (IoT) is the bright future of connected technology, yet remains underutilized by healthcare organizations. In a preview presentation by Paul Perry, director of Warren Averett security services, IoT is highlighted for is benefits with connected health.

In an effort to keep hospital rooms safe from drug-resistant organism for providers, patients and their families, Iredell Health System has implemented ultraviolet (UV) technology to better detect those pathogens.

Upstep (https://www.upstep.com), founded by Israeli entrepreneurs, is launching a comprehensive online service to buy custom made orthotics designed by world-class podiatrists. Prices represent 35%-50% savings over the direct purchase from podiatrists.

Testing for carcinogens, pollution and contaminants involves an array of large and expensive sensors accompanied by a trained professional. Researchers have introduced, in ACS Sensors, a new detection system utilizing portable, low-cost sensors paired with a smartphone application to fast track results with high accuracy.

Being woken in the middle of the night is an unpleasant experience for anyone, but especially patients in the hospital undergoing their nightly vital sign check. Researchers from Ohio State University conducted a study, published in Patient Experience Journal, on reported quality of sleep and patient’s satisfaction during as hospital stay where overnight vital signs were collected compared to when vitals were not taken.

Bayer has received approval for a supplemental Biologics License Application (sBLA) from the U.S. Food and Drug Administration (FDA) in regards to their myBETAapp™ and the BETACONNECT Navigator™. These platforms utilize software to allow patients with multiple sclerosis to auto-administer BETASERON.